SSI Strategy

Our Leadership Team

We are proven innovators from the management consulting and pharmaceutical industries. Our collective expertise in medical affairs, regulatory, clinical development and operations,

Meet the Team

Leadership Team

We are proven innovators from the management consulting and pharmaceutical industries. Our collective expertise in medical affairs, regulatory, clinical development and operations, pharmacovigilance, clinical and academic practice paired with change, project, and organizational management drives strategic thought partnership to execution with our clients

Doug Locke

SSI CEO & Medical Model Transformation Expert

Doug is a consultant and relationship manager with over twenty-five years of domestic and international management experience and is currently serving a dual role of CEO of SSI Strategy and President at Acquis Consulting. Together, these organizations prove that there is an unmet need for program management and scientific support services in Medical Affairs, Clinical, PV, and Regulatory disciplines among other functions in the CMO’s purview.

He works with client leaders to tackle the challenges of the Medical Office within small and mid-sized organizations – often focusing on companies with unique modalities or first to market concepts. He is also adroit in USMA and GMA reengineering efforts for larger client partners. Doug is responsible for some of the company’s longest lasting client partnerships. In collaboration with the many incredible Medical Team and Consultant Team colleagues, he strives to create agile and lasting models for our client partners.

Doug is responsible for oversight of all SSI activities spanning the company’s five offices and maintains over P&L responsibility. He is also working with client leaders on domestic and international projects.

DOUG LOCKE

Chief Executive Officer

JOHAN STROMQUIST

President, NDA Group

Adam Schwartz, PMP

President

Adam is a management consultant with over 15 years of consulting experience across a diverse group of clients. He has spent most of his career working with Life Science industry clients to devise and execute their business strategies. Adam’s consulting experience ranges from Program and Project Management to Business Process Reengineering, Systems Implementation, and Change Management.

Adam began working with SSI Strategy in 2012 in an effort to further his consulting work in the Life Science industry. At SSI Strategy, Adam focuses on developing and delivering new solutions for clients as well as acting as a member of the executive team.

Adam is currently supporting a team of consultants in developing new methodologies for prioritizing Medical Affairs activities and measuring the function’s impact. At another client organization, he is leading a team in the development of new policies and procedures to support a growing Medical Affairs team.

Adam is a hands-on manager and an expert at leveraging his system’s knowledge and business acumen in order to ensure that the solutions delivered by his project team meet the critical needs of the business.

He is the Treasurer of the NY / NJ Chapter of PDMA (Product Development and Management Association). Adam holds a Bachelor of Science degree in Management Information Systems from Miami University and is a PMI (Project Management Institute) certified PMP (Project Management Professional).

ADAM SCHWARTZ

President

Kim Kushner

Chief Business Officer

Kim is a strategist with over a decade of experience across the healthcare industry. She has spent the last eight years in a consulting capacity, assisting senior leaders in devising strategies that demonstrate value to their organizations in new ways. Kim has industry experience across pharmaceuticals, medical devices, diagnostics, payers, providers, government, nonprofits, and has worked across some of the industry’s most innovative modalities (including gene therapy and digital therapies). She has functional experience in operational strategy, value realization, organizational design, data analytics, and program management. Kim thrives in new challenges and problem solving.

Over the last four years, Kim has focused on designing and executing innovative strategies across medical affairs, clinical affairs/development, and safety. In her role, she works closely with C-Suite leadership, and other client leaders, to drive innovation in the medical space and execute sustainable, realistic, customized solutions. She has led multiple initiatives to demonstrate the value case for investments in the Medical Office.

Prior to joining SSI Strategy, Kim was a manager in Accenture’s health strategy practice where her primary area of expertise was the design and mobilization of data and analytics strategies for healthcare payers and providers. During her tenure, she developed the foundational business case framework to demonstrate the quantitative and qualitative value of investments in enterprise and patient-level analytics.

Preceding these experiences Kim worked in development/non-profit management, government, and patient advocacy/lobbying. Her non-profit and government experiences have taught her to creatively do much more with less.

Outside of her responsibilities at SSI, Kim teaches a course on consulting in the healthcare industry at the Yale School of Public Health. She also serves as the Chair of the Junior Board of Advisors for the American Cancer Society in New York City.

KIM KUSHNER

Chief Business Officer

Craig Ungaro

Chief Financial Officer 

Craig Ungaro is the Chief Financial Officer for SSI Strategy.  Craig has over 20 years of diverse experience across Investment Banking and Corporate Finance for both public and private companies.  Prior to joining SSI, he was the North American finance leader for Gartner Consulting where he helped scale the Consulting business.  Additionally, Craig has deep experience in the Healthcare and Life Sciences industries.  As a member of the finance team at IMS Health (now IQVIA), he supported revenue and profitability expansion and ultimately taking the company public through an IPO.  Prior to IMS, he worked at Thomson Healthcare (now part of IBM Watson Health) where he was focused on Mergers & Acquisitions.  Craig is passionate about helping companies achieve their strategic and financial growth objectives and increasing operational effectiveness.

Craig holds a Master’s in Business Administration from Duke University and a Bachelor of Sciences degree in Finance from the University of Virginia.  Craig resides in Connecticut with his wife and two children.

CRAIG UNGARO

Chief Financial Officer